An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Online
Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could result in individuals administering products of uncertain source.
Some experts said the demand for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.
Platform Response and Material Removal
According to TikTok, the platform has removed violative content and banned associated hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Operations
Investigations also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.
Within moments of entering one community, a seller shared contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.
Item Details and Pricing
Within these groups, messages show dark colored parcels with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has previously seen patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly significant health risks”.
